- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/46 - Sulfur atoms
Patent holdings for IPC class C07D 263/46
Total number of patents in this class: 70
10-year publication summary
|
3
|
7
|
11
|
9
|
8
|
4
|
9
|
2
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10162 |
11 |
| North Carolina State University | 1607 |
4 |
| Gwangju Institute of Science and Technology | 854 |
3 |
| Industry-Academic Cooperation Foundation, Yonsei University | 2441 |
3 |
| The Institute of Cancer Research: Royal Cancer Hospital | 183 |
3 |
| IFM Tre, Inc. | 5 |
3 |
| Merck Sharp & Dohme LLC | 3715 |
3 |
| The General Hospital Corporation | 4924 |
2 |
| Takeda Pharmaceutical Company Limited | 2695 |
2 |
| Kyungpook National University Industry-Academic Cooperation Foundation | 1261 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4902 |
2 |
| The Regents of the University of Colorado, a body corporate | 2860 |
2 |
| Symrise AG | 1864 |
2 |
| Trustees of Dartmouth College | 1121 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3384 |
2 |
| Seoul National University R&db Foundation | 4307 |
2 |
| Novartis Inflammasome Research, Inc. | 10 |
2 |
| Projini Agchem Ltd | 3 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Bayer Cropscience AG | 1811 |
1 |
| Other owners | 16 |